Table 1

Adult survival statistics for all trials.
Trial
 Concentration (μM)
 Mean lifespan (days)
 Relative survival (%)
 p (Logrank)
 n (failed, censor)







Treated
 Control


Resveratrol-trimethylether
1
 100
 9.7
 12.16
 80%
 0.004
 61,0
4
 20
 7.72
 11.26
 69%
 < 0.001
 61,0
4
 40
 7.72
 11.26
 69%
 < 0.001
 74,0
4
 100
 7.18
 11.26
 64%
 < 0.001
 70,2
5
 5
 18.83
 18.49
 102%
 0.91
 46,3
5
 20
 16.41
 18.49
 89%
 0.055
 42,3
5
 100
 15.18
 18.49
 82%
 0.005
 37,6
6
 20
 9.02
 15.32
 59%
 < 0.0001
 49,5
6
 40
 7.98
 15.32
 52%
 < 0.0001
 51,0
6
 100
 7.54
 15.32
 49%
 < 0.0001
 52,0
3-OH-5,4'- dimethoxystilbene
1
 100
 6.34
 12.16
 52%
 < 0.0001
 53,0
2
 20
 11.05
 11.05
 100%
 0.986
 47,2
2
 40
 10.52
 11.05
 95%
 0.234
 40,1
6
 20
 10.38
 15.32
 68%
 < 0.0001
 56,0
6
 40
 7.68
 15.32
 50%
 < 0.0001
 54,1
6
 100
 6.56
 15.32
 43%
 < 0.0001
 55,3
Pterostilbene
1
 100
 9.55
 12.16
 79%
 0.005
 69,9
4
 20
 10.43
 11.26
 93%
 0.336
 54,0
4
 40
 10
 11.26
 89%
 0.035
 65,1
4
 100
 8.07
 11.26
 72%
 < 0.0001
 51,1
6
 20
 13.72
 15.32
 90%
 0.058
 55,1
6
 40
 14.41
 15.32
 94%
 0.142
 51,4
6
 100
 10.98
 15.32
 72%
 < 0.001
 51,0
Desoxyrhapontigenin
1
 100
 10.64
 12.16
 88%
 0.12
 61,1
3
 100
 11.31
 15.37
 74%
 < 0.0001
 36,0
3
 200
 11.61
 15.37
 76%
 < 0.0001
 44,1
4
 20
 10.2
 11.26
 91%
 0.12
 74,0
4
 40
 10.38
 11.26
 92%
 0.11
 71,2
4
 100
 9.44
 11.26
 84%
 0.003
 50,0
6
 20
 14.18
 15.32
 93%
 0.494
 54,3
6
 40
 15.31
 15.32
 100%
 0.48
 59,1
6
 100
 13.63
 15.32
 89%
 0.027
 46,9
Pinostilbene
1
 100
 13.6
 12.16
 112%
 0.062
 68,1
2
 20
 10.04
 11.05
 91%
 0.266
 55,0
2
 40
 11.53
 11.05
 104%
 0.319
 42,5
3
 100
 16.9
 15.37
 110%
 0.448
 41,0
3
 200
 15.23
 15.37
 99%
 0.411
 42,5
6
 20
 14.24
 15.32
 93%
 0.319
 56,3
6
 40
 17.33
 15.32
 113%
 0.085
 60,0
6
 100
 16.24
 15.32
 106%
 0.724
 51,2
Resveratrol
1
 100
 12.18
 12.16
 100%
 0.867
 70,3
2
 20
 11.85
 11.05
 107%
 0.182
 48,4
2
 40
 10.53
 11.05
 95%
 0.924
 55,0
3
 100
 16.64
 15.37
 108%
 0.435
 30,4
3
 200
 17
 15.37
 111%
 0.337
 38,0
6
 20
 14.65
 15.32
 96%
 0.804
 54,5
6
 40
 16.17
 15.32
 106%
 0.501
 59,0
6
 100
 17.55
 15.32
 115%
 0.055
 58,0
Piceatannol
2
 20
 11.72
 11.05
 106%
 0.362
 44,0
2
 40
 11.58
 11.05
 105%
 0.5
 37,9
3
 100
 17.78
 15.37
 116%
 0.094
 55,1
3
 200
 17.5
 15.37
 114%
 0.166
 55,1
6
 20
 13.71
 15.32
 89%
 0.231
 50,1
6
 40
 15.63
 15.32
 102%
 0.75
 50,1
6
 100
 16.6
 15.32
 108%
 0.146
 50,1

Wilson et al. BMC Pharmacology 2008 8:15   doi:10.1186/1471-2210-8-15